These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 27017703)

  • 41. The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines.
    Saitoh A; Sugiyama A; Yamada M; Inagaki M; Oka J; Nagase H; Yamada M
    Neuropharmacology; 2013 Apr; 67():485-93. PubMed ID: 23246531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze.
    Mansouri MT; Soltani M; Naghizadeh B; Farbood Y; Mashak A; Sarkaki A
    Pharmacol Biochem Behav; 2014 Feb; 117():40-6. PubMed ID: 24345572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
    Mak P; Broussard C; Vacy K; Broadbear JH
    J Psychopharmacol; 2012 Apr; 26(4):532-42. PubMed ID: 21890582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    Wierońska JM; Papp M; Pilc A
    Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethological comparison of the effects of a bovine alpha s1-casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety.
    Violle N; Messaoudi M; Lefranc-Millot C; Desor D; Nejdi A; Demagny B; Schroeder H
    Pharmacol Biochem Behav; 2006 Jul; 84(3):517-23. PubMed ID: 16899284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice.
    Zhao H; Ohinata K; Yoshikawa M
    Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):68-72. PubMed ID: 19007903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
    Stern CA; Carobrez AP; Bertoglio LJ
    Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze.
    Pinheiro SN; Del-Ben CM; Zangrossi H; Graeff FG
    J Psychopharmacol; 2008 Mar; 22(2):132-7. PubMed ID: 18208911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice.
    Vargas KM; Da Cunha C; Andreatini R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1394-402. PubMed ID: 16828217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coriandrum sativum: evaluation of its anxiolytic effect in the elevated plus-maze.
    Emamghoreishi M; Khasaki M; Aazam MF
    J Ethnopharmacol; 2005 Jan; 96(3):365-70. PubMed ID: 15619553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anxiolytic-like effect of asiaticoside in mice.
    Chen SW; Wang WJ; Li WJ; Wang R; Li YL; Huang YN; Liang X
    Pharmacol Biochem Behav; 2006 Oct; 85(2):339-44. PubMed ID: 17059844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A critical test of the hippocampal theta model of anxiolytic drug action.
    Yeung M; Treit D; Dickson CT
    Neuropharmacology; 2012 Jan; 62(1):155-60. PubMed ID: 21723303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze.
    Alcalay RN; Giladi E; Pick CG; Gozes I
    Neurosci Lett; 2004 May; 361(1-3):128-31. PubMed ID: 15135910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
    Rodgers RJ; Wright FL; Snow NF; Taylor LJ
    Behav Brain Res; 2013 Apr; 243():213-9. PubMed ID: 23333844
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral administration of a μ-opioid receptor agonist DAMGO suppresses the anxiolytic and stimulatory effects of caffeine.
    Sudakov SK; Nazarova GA; Alekseeva EV; Kolpakov AA
    Bull Exp Biol Med; 2015 Jan; 158(3):295-7. PubMed ID: 25573353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anxiogenic effect of low-dose methamphetamine in the test of elevated plus-maze.
    Pometlová M; Nohejlová-Deykun K; Slamberová R
    Prague Med Rep; 2012; 113(3):223-30. PubMed ID: 22980563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata linneaus: a comment on medicinal plants' standardization.
    Dhawan K; Kumar S; Sharma A
    J Altern Complement Med; 2002 Jun; 8(3):283-91. PubMed ID: 12165186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.